SCHEMBL4199997

SCHEMBL4199997

N#CCC1C=CN=C(N2CCN(c3ncccn3)CC2)N1c1nc2ccccc2s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.42
DRD2 P14416 4/20 0.42
HTR7 P34969 4/20 0.42
DRD4 P21917 2/20 0.42
DRD3 P35462 2/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2C P18825 1/20 0.42
SLC6A2 P23975 1/20 0.42
ADRA1A P35348 1/20 0.42
HRH1 P35367 1/20 0.42
HTR2B P41595 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
HTR2A P28223 3/20 0.42
SORD Q00796 1/20 0.39
NPC1 O15118 8/20 0.39
RAB9A P51151 8/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4199975 0.89 NPC1 (0.40) SORDNPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4198007 0.89 RAB9A (0.42) DRD4NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL4197293 0.87 SORD (0.40) HTR1ADRD2HTR7DRD4DRD3
SCHEMBL4197211 0.87 SCN4A (0.38) NPC1RAB9ASMN1; SMN2CYP1A2CYP2D6
SCHEMBL4197998 0.87 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2CYP2D6
SCHEMBL4195581 0.86 USP2 (0.52) HTR1ADRD2HTR7DRD4DRD3
SCHEMBL4964716 0.86 SORD (0.35) HTR1ADRD2HTR7DRD4DRD3
SCHEMBL4195517 0.86 DPP4 (0.40) SORDNPC1RAB9ASMN1; SMN2CYP1A2
Acetonitrile SCHEMBL6828681 0.84 SORD (0.38) HTR1ADRD2HTR7DRD4DRD3
SCHEMBL4197930 0.83 RAB9A (0.40) NPC1RAB9ASMN1; SMN2CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2026802-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES Laboratoires Serono SA (CH) 2009-02-25 EP disclosed
WO-2007141224-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES LABORATOIRES SERONO SA (CH) 2007-12-13 WO disclosed